黃玄舜副研究員

 

Huang Hsuan Shun 黃玄舜 副研究員    Dr. Huang, Hsuan-Shun
E-mailEmail住址會使用灌水程式保護機制。你需要啟動Javascript才能觀看它
分機:17660
Tzu Chi University, Taiwan. Ph.D.
專長:Molecular Oncology, Immunoregulation                  

 

 

 

 

 

 

 

 


研究興趣
     

高級別漿液性卵巢癌的成因不明,多在晚期才發現,為死亡率最高的女性特有癌症。隨著全球工業化社會轉型、人口老化、女性少育、晚婚等因素,卵巢癌的威脅逐年上升成為婦科最大死因。我們以臨床檢體及分子細胞生物技術為基礎,在先前的研究已發現排卵濾泡液的自由基及經血倒流的血紅素為致癌初始因子與協助因子,目前正一步步釐清濾泡液中致癌驅化因子,從分子層面,試圖拼出卵巢癌形成模式。本系列研究除了增進癌症病因學的發展外,更重要的是希望能提供卵巢癌初級預防及次級預防的重要資訊,以期減緩現代婦女遭受此疾病的威脅

 

The current research in our team focuses on the etiology of ovarian cancer. This cancer is the fifth leading cause of death of female cancer worldwide. The five-year mortality rate is 60% and the vast majority of deaths are from the histology type of high-grade serous ovarian carcinoma (HGSC) [high-grade means poorly differentiated], accounting for the number one killer of gynecological cancers. The poor prognosis of ovarian HGSC is mainly due to the elusive etiology and the lack of early symptoms or signs for diagnosis. The recent breakthrough findings indicate that fallopian tube fimbriae are the real origin of ovarian HGSC and incessant ovulation is a major risk. Fallopian tube fimbriae approach ovulatory follicle and pick the oocytes after ovulation. We speculated that there might be some carcinogens in the ovulating follicular fluid (FF) that initiate the transformation of fimbria epithelium.

We have established in vitro, in vivo and ex vivo models to recapitulate many of the ovulating effects on fallopian tube fimbriae. These include HPV E6/E7-immortalized human fimbrial epithelial cell line (FE25), ex vivo-cultured human and mouse fimbria tissue as well as Tp53-null transgenic mice, each exposed to human FF aspirates and its carcinogenic components. We have discovered two cancer initiation culprits of fimbria carcinogenesis, conferring the original etiology of ovarian HGSC: ROS in ovulatory FF was the main mutagen that can cause DNA double strand break (DSB) of fimbrial epithelial cells and hemoglobin from retrograde menstruation was the auxiliary surviving factor that alleviated the NOX1-mediated cell apoptosis under the oxidative and DNA damaged stress. However, only these two factors cannot fully transform immortalized cells, there are other unknown carcinogens required to be discovered. I continue to investigate the ovulation-induced carcinogenesis of fallopian tube epithelium. I hope, by using the clinical specimens-based in vitro and in vivo research models, we will achieve a clear picture of the transformation process of ovulation-induced fimbral carcinogenesis, and pave ways to primary and secondary prevention of ovarian HGSC.

  

成果發表(5年內)

1.

Hsuan-Shun Huang, Pao-Chu Chen, Sung-Chao Chu, Ming-Hsun Lee, Chi-Ya Huang, Tang-Yuan Chu* (2021, Sep). Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation   . Neoplasia, 2021 Nov;23(11):1123-1136.. (SCI, 72/242 Oncology). MOST 108-2314-B-303-005-MY2.
本人為第一作者.

2.

Hsuan-Shun Huang, Sung-Chao Chu, Pao-Chu Chen, Ming-Hsun Lee, Chi-Ya Huang, Hsien-ming Chou, Tang-Yuan Chu (2021, Aug). Insuline-Like Growth Factor-2 (IGF2) and Hepatocyte Growth Factor (HGF) Promote Lymphomagenesis in p53-null Mice in Tissue-specific and Estrogen-signaling Dependent Manners. Journal of cancer, 2021; 12(20):6021-6030. (SCI, 131/308 ONCOLOGY ). MOST 108-2314-B-303-005-MY2. 本人為第一 作者.

3.

Mei J, Tian H, Huang HS, Hsu CF, Liou Y, Wu N, Zhang W, Chu TY. (2021, May). Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis. cell proliferation, 2021 May;54(5):e13029.. (SCI, 46/195, Cell biology).

4.

Na-Yi Yuan Wu, Chao Fang, Hsuan-Shun Huang, Jing Wang, Tang-Yuan Chu(2020, Jan). Natural history of ovarian high-grade serous carcinoma from time effects of ovulation inhibition and progesterone clearance of p53-defective lesions. Modern Pathology , 33(1):29-37. (SCI, 6/77, pathology). MOST 107-2314-B-303-013-MY3.

5.

Che-Fang Hsu*, Hsuan-Shun Huang*, Pao-Chu Chen, Dah-Ching Ding, TangYuan Chu (2019, Feb). IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation. EBioMedicine. (Accepted). (SCI, 17/140,MEDICINE, RESEARCH & EXPERIMENTAL). MOST 106- 2014-B-302-001-MY2. 本人為第一作者.

6.

Chan H.,* Huang H. S.,* Sun D. S.,* Lee C. J.,* Lien T. S. and Chang H. H. (2018, Jan). TRPM8 and RAAS-mediated hypertension is critical for coldinduced immunosuppression in mice. Oncotarget, 30;9(16):12781-12795. (SCIE, 44/217, ONCOLOGY). 本人為第一作者.

7.

Wu, N. Y., Huang, H.S., Chao, T. H., Chou, H. M., Fang, C., Qin, C. Z., Tzeng, Y.J., Lin, C. Y., Chu, T. Y.,* Zhou, H. H.,* (2017, Mar). Progesterone prevents high grade serous ovarian cancer by induction necroptosis in p53-defective Fallopian tube epithelium.. Cell Reports, 18(11):2557–2565.. (SCI, 33/195, cell biology). MOST 99-2628-B-303-001-MY3.

8.

Fang C., Chen Y. X., Wu N. Y., Yin J. Y., Li X. P., Huang H. S., Zhang W., Zhou H.H., Liu Z. Q. (2017, Jan). MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3amediated NER signaling pathway. . Scientific Reports, 11;7:40384.. (SCI, 7/63).

9.

Huang, H.S., Chu, S.C., Hsu, C.F., Chen, P.C., Ding, D. C., Chang, M.Y., and Chu, T.Y. (2016, Nov). Haemoglobin in pelvic fluid rescues Fallopian tube epithelial cells from reactive oxygen species stress and apoptosis. Journal of pathology, 240(4):484-494. (SCI, 5/77 , PATHOLOGY). 本人為第一作者.

10.  Hsieh, I.J., Huang, H.S., and Chang, M.Y. (2016, Oct). Anticancer activity of Kalanchoe tubiflora extract against human lung cancer cells in vitro and in vivo. Environmental Toxicology, 31(11):1663-1673. (SCI, 21/98, WATERRESOURCES).
本人為第一作者.
11. Zhang T., Shao Y., Chu T. Y., Huang H. S., Liou Y. L., Li Q., Zhou H. H. (2016, May). MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells. . American Journal of Cancer Research, 1;6(5):957-72.. (SCI, 81/213).

 

聯絡資訊

花蓮市中央路三段707號協力樓6-9樓

服務電話:03-8561825                      

傳真號碼:03-8573710

E-Mail:grantcheck630@gmail.com

意見反映 :https://goo.gl/N7TZWF

歡迎追蹤我們!Follow Us!
         

行政辦公室

姓名 分機   業務內容
游文君 小姐  12116   綜理研究行政
藍陳淯 先生  15631   專利技轉、產學合作、市場開發和院內計畫
林玉琴 小姐  13110   主辦「計畫」
王天佑 先生  12147   主辦研究成果:論文發表費、研究獎勵金
董玟慧 小姐  15639   產學合作、計畫經費核銷
廖月鳳 小姐  12145   主辦學術協助:英修(editing)送件、
      Grammarly服務窗口、研究訊息推播
陳淑貴 小姐  15630   主辦「行政協助作業」

Search